β-Elemene - An Overview
a press release by you, made under penalty of perjury, that the above mentioned data with your detect is correct and you are the copyright owner or authorized to act to the copyright proprietor's behalf.These preclinical observations aid the hypothesis that tucidinostat will likely be efficacious in ATLL.The trial should have a 2-arm design and can